Therapeutic regimen in the medical treatment of cancer pain
Rodríguez López, M.J.; Marín Muñoz, M.; de la Torre Liébanas, M.R.; Muñoz de la Guardia, J.L.
Revista Espanola de Anestesiologia y Reanimacion 35(1): 36-39
1988
ISSN/ISBN: 0034-9356 PMID: 3353551 Document Number: 325714
Document emailed within 1 workday
Related Documents
Kiba, T.; Okada, Y.; Kajiume, S.; Yamaguchi, A. 2015: Two cases of pancreatic cancer treated with FOLFIRINOX regimen and G-CSF prophylaxis at the standard therapeutic dose Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(5): 629-632Thornfeldt, C.; Rizer, R.L.; Trookman, N.S. 2013: Blockade of melanin synthesis, activation and distribution pathway by a nonprescription natural regimen is equally effective to a multiple prescription-based therapeutic regimen Journal of Drugs in Dermatology: Jdd 12(12): 1449-1454
Martino, G.; Frusciante, V.; Varraso, A.; Barbano, F.; Capotorto, A.; Dicembrino, F.; Petruzzelli, F.; Rubini, G. 1999: Efficacy of 51Cr-EDTA clearance to tailor a carboplatin therapeutic regimen in ovarian cancer patients Anticancer Research 19(6c): 5587-5591
Kumps, A. 1982: Therapeutic surveillance of anti-epileptic drugs. Determination of dosage regimen and monitoring of treatment Acta Neurologica Belgica 82(4): 209-214
Kantayaporn, C.; Patumanond, J.; Tawichasri, C.; Chattrapiban, T. 2009: Pain reduction of a pain management regimen in orthopedic patients at Lamphun Hospital Journal of the Medical Association of Thailand 92(Suppl 6): S217-S220
Duchemann, B.; Zelek, L. 2017: Cancer treatment. Surgery, radiotherapy, medical treatments (chemotherapy, targeted therapies, immunotherapy). Multidisciplinary therapeutic decision and patient information La Revue du Praticien 67(10): E499-E509
Paster, R.Z.; McAdoo, M.A.; Keyserling, C.H.; Nemeth, M.A.; Tack, K.J.; Griffin, T.J. 2000: A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis International Journal of Clinical Practice 54(5): 293-299
L.P.ole, C.; Weijmer, M.; Van Ittersum, F.; Valentijn, R.; Ter Wee, P. 2002: Outcome of routine laboratory data after 30 weeks of treatment with a PD regimen low in glucose and GDPs or a standard PD regimen in newly CAPD patients Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 200A
Jørgensen, B.C.; Andersen, H.B.; Engquist, A. 1980: Epidural morphine. Treatment of cancer pain and postoperative pain Ugeskrift for Laeger 142(35): 2266-2270
Ruiz López, R. 1993: The treatment of pain. 3. Cancer pain and palliative care Revista de Enfermeria 16(182): 25-29
Martoni, A.; Cricca, A.; Guaraldi, M.; Covizzi, M.; Farris, A.; Pannuti, F. 1992: Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer Anticancer Research 12(3): 607-612
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Koehler, M.; Bubała, H.; Hałatek, M. 1988: Infections in children during treatment of acute lymphoblastic leukemia according to Riehm's regimen. analysis of material from the I pediatric clinic of the Silesian Medical Academy in Zabrze from 1982-1986 Pediatria Polska 63(12): 771-776
Sato, Y. 2007: An attitude survey on the medical use of narcotics for cancer pain relief Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(13): 2267-2270
Lorvidhaya, V.; Katanyoo, K.; Srisomboon, J.; Suprapaphorn, P.; Cheewakriangkrai, C. 2004: Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain Journal of the Medical Association of Thailand 87(3): 319-325
Kitada, N.; Morita, S.; Morimoto, S.; Yamasaki, H.; Fujii, C.; Anami, S.; Fukunaga, M.; Furukawa, H.; Takara, K.; Yokoyama, T.; Watari, M. 2008: Comparative survey on current status and the differences of treatment using modified FOLFOX6 regimen in patients with colorectal cancer in two general hospitals Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(7): 1175-1180
Shimizu, Y.; Nakayama, K.; Seimiya, Y.; Yamakawa, Y.; Koi, S.; Yokosuka, K.; Teshima, H.; Chen, J.T.; Fujimoto, I.; Yamauchi, K. 1991: Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin Nihon Sanka Fujinka Gakkai Zasshi 43(5): 549-556
Kohno, T.; Obata, H. 2011: Mechanisms of action of therapeutic agents in the treatment of chronic pain in the spinal cord Masui. Japanese Journal of Anesthesiology 60 Suppl: S113-S120
Pariser, D.; Bucko, A.; Fried, R.; Jarratt, M.T.; Kempers, S.; Kircik, L.; Lucky, A.W.; Rafal, E.; Rendon, M.; Weiss, J.; Wilson, D.C.; Rossi, A.B.; Ramaswamy, R.; Nighland, M. 2010: Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen Journal of Drugs in Dermatology: Jdd 9(7): 805-813
Galeone, M.; Cacioli, D.; Moise, G.; Bossi, M.C.; Lensi, C.; Monti, G. 1983: Use of cimetidine in gastroduodenal ulcer. new therapeutic regimen Minerva Dietologica e Gastroenterologica 29(3): 207-213